NF-kappaB expression predicts clinical outcome for nasal polyposis

Area of Science:

• Immunology
• Molecular Biology
• Otolaryngology

Background:

• Nasal polyps are inflammatory growths in the nasal cavity.
• Glucocorticoids are a common treatment for nasal polyps.
• Mechanisms of glucocorticoid resistance in nasal polyps are not fully understood.

Purpose of the Study:

• To investigate the correlation between clinical prognosis and the expression of p65, c-Fos, GRalpha, and GRbeta in patients with nasal polyps.
• To identify potential molecular markers for predicting treatment response in nasal polyps.

Main Methods:

• Gene expression analysis using Real Time-PCR on biopsy samples from 20 nasal polyp patients and 8 controls.
• Correlation of gene expression levels (p65, c-Fos, GRalpha, GRbeta) with clinical outcomes over a 30-month follow-up.
• Defining surgical indication as an endpoint for glucocorticoid therapy resistance.

Main Results:

• Nasal polyp patients exhibited significantly higher p65 expression (P<0.05) compared to controls.
• A lower expression of GRalpha (P<0.0001) and a reduced GRalpha/GRbeta ratio (P<0.0001) were observed in nasal polyp patients.
• Elevated p65 expression in nasal polyps correlated with a poorer response to glucocorticoids, increasing the risk of surgery by four-fold (P<0.05).

Conclusions:

• Nasal polyps are characterized by increased p65 (NFkappaB) and decreased GRalpha expression.
• Higher p65 expression at diagnosis is associated with reduced efficacy of medical treatment.
• This suggests that elevated p65 may be a key mechanism underlying glucocorticoid resistance in nasal polyps.